Unleash the power of genomic data

Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world – and realise the potential of precision medicine.

Our expertise has led genomic data development for a decade, as our people have worked with pioneers such as the University of Cambridge and Genomics England.

Today, Zetta Genomics partners with healthcare systems, the life sciences and global health-techs to realise a future that will ensure that precision medicine is available to everyone.

Group 1000004299

Native
technology

XetaBase is a genomic-native technology – built on the open-source, OpenCB software platform to meet the scale, speed and re-interpretation demands of genomic medicine.
Group 1000004262

Scale
your data

XetaBase encompasses genomic scale: the greater the volume and complexity, the greater the insight and outcomes.
Group 1000004264

Accelerates
data management

XetaBase accelerates data management and the cost-effective application of genomic data in the lab and clinic.
Group 1000004210

Unique
platform

The unique XetaBase platform simplifies tertiary analysis: aggregating, indexing and enriching secondary genomic data – enabling continual re-interpretation – to unlock research and clinical insight.

Unique
platform

The unique XetaBase platform simplifies tertiary analysis: aggregating, indexing and enriching secondary genomic data – enabling continual
re-interpretation – to unlock research and clinical insight.

Accelerates data management

XetaBase accelerates data management and the cost-effective application of genomic data in the lab and clinic.

Scale
your data

XetaBase encompasses genomic scale: the greater the volume and complexity, the greater the insight and outcomes.

Native
technology

XetaBase is a genomic-native technology – built on the open-source, OpenCB software platform to meet the scale, speed and re-interpretation demands of genomic medicine.

Zetta technologies

Zetta Genomics delivers genomic data management fit for the precision medicine age.

XetaBase is a uniquely ‘genomic native’ technology. It is built on the open-source OpenCB platform – developed by and for world-leading genomic research and data scientists. Global development has been led by OpenCB’s chief architect and Zetta Genomics co-founder, Ignacio Medina.

XetaBase is a completely novel solution to the challenges of genomic data. It sweeps away obsolete flat file approaches to bring meaningful and actionable genomic data into the lab and the clinic. XetaBase empowers continual re-interpretation, while scaling seamlessly as databases grow to encompass millions of whole genome sequences.

Zetta people

Zetta Genomics brings together a wealth of talent and diversity.

We simplify complex problems, holding ourselves to the highest standards as we work to make a positive impact on millions, perhaps billions, of lives around the world.

To achieve these powerful goals, we have the freedom to explore and try new and innovative approaches. We collaborate, support and respect each other, our partners and clients within a happy working environment. We ensure that everyone has a voice, is valued and is empowered to succeed. Simply, our mission is too important not to.

Zetta potential

We understand the importance of our
work and the potential of our technology.

Our technology is an enabler across virtually every research and clinical field in genomics, with the power to drive – and be driven by – advances in precision medicine. Our technologies help researchers and clinicians to make better, faster and more insightful decisions. Our ambition is to see XetaBase contribute to ever-more effective collaboration, inspire existing and new avenues of discovery – and ultimately change the lives of millions of people for the better. Zetta Genomics unleashes genomic data to realise the incredible power of precision medicine – and revolutionise healthcare for everyone.

Mark Bailey, CEO, Zetta Genomics

Architecting the future of predictive genomics – a blueprint for health economies and systems

Co-founder Ignacio ('Nacho') Medina and CFO Bryony Burrows with some of the Zetta team in the Valencia office, which opened in 2022.

Zetta Genomics secures £1.9 million in second round seed funding to configure for scale, delivery and innovation

XetaBase 1.2.14 Release Notes

XetaBase 1.5.1 Release Notes

In January, our Lead Bioinformatics Consultant at Zetta Genomics, Marta Bleda Latorre, was at Festival of Genomics 2023

Four key challenges to address when building a genome-optimised analysis platform

XetaBase Release Notes 1.5.0

XetaBase 1.5.0 Release Notes

Mark Bailey, CEO, Zetta Genomics

Architecting the future of predictive genomics – a blueprint for health economies and systems

Co-founder Ignacio ('Nacho') Medina and CFO Bryony Burrows with some of the Zetta team in the Valencia office, which opened in 2022.

Zetta Genomics secures £1.9 million in second round seed funding to configure for scale, delivery and innovation

XetaBase 1.2.14 Release Notes

XetaBase 1.5.1 Release Notes

In January, our Lead Bioinformatics Consultant at Zetta Genomics, Marta Bleda Latorre, was at Festival of Genomics 2023

Four key challenges to address when building a genome-optimised analysis platform

XetaBase Release Notes 1.5.0

XetaBase 1.5.0 Release Notes

partnership

Our partners

Zetta partners with like-minded organisations from both public and private sectors.

contact us

Let Zetta Genomics unleash the power of your genomic data

Let Zetta Genomics unleash
the power of your genomic data